HYBRID PEPTIDES: A NEW CLINICAL FRONTIER

Chimera sequences represent a rapidly developing area in drug discovery, offering a novel approach to target previously challenging conditions. Such designed assemblies integrate several amino acid segments, allowing for enhanced selectivity to diverse targets and potentially circumventing therap